$22.72
0.190.84%
Last update: Oct 30, 4:33 PM
Tango Therapeutics Inc (TNGX) Stock Price, Quote, News & History
TNGXNASDAQ
Tango Therapeutics reports an 82% response rate in pancreatic cancer trials and prepares a randomized registrational study for early 2027.
You can purchase shares of Tango Therapeutics (NASDAQ:TNGX) through any online brokerage.
Other companies in Tango Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Tango Therapeutics has a consensus price target of $37.00.
The stock price for Tango Therapeutics (NASDAQ: TNGX) is $22.72 last updated October 30, 2026 at 4:33 PM EDT.
There are no upcoming dividends for Tango Therapeutics.
Tango Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Tango Therapeutics.
Tango Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing...
